Related Experiment Video

Updated: Apr 20, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K

Does CircuLite Synergy assist device as partial ventricular support have a place in modern management of advanced

Prashant N Mohite1, Anton Sabashnikov, Andre Ruediger Simon

  • 1Department of Cardiothoracic Transplantation and Mechanical support, Royal Brompton and Harefield NHS Foundation Trust, London, UK.

Expert Review of Medical Devices
|December 3, 2014
PubMed

Insights

The Synergy Micro-pump offers partial hemodynamic support for heart failure patients, serving as a less invasive alternative to full-support left ventricular assist devices (LVADs) for bridging transplantation.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • The shortage of donor hearts necessitates advanced mechanical circulatory support.
  • Conventional left ventricular assist devices (LVADs) offer full hemodynamic support but require extensive surgery.
  • Severe heart failure patients not yet eligible for full-support LVADs need alternative treatment options.

Purpose of the Study:

  • To review the clinical application of the Synergy Micro-pump.
  • To evaluate its role in providing partial hemodynamic support.
  • To highlight its benefits as an early intervention strategy.

Main Methods:

  • Review of clinical data on the Synergy Micro-pump.
  • Analysis of its implantation procedure and support capacity.
  • Comparison with conventional full-support LVADs.

Main Results:

  • The Synergy Micro-pump is the smallest implantable LVAD, providing partial flow support up to 3 l/min.
  • Its small size allows implantation without cardiopulmonary bypass or sternotomy.
  • Early intervention with this device shows substantial patient benefits.

Conclusions:

  • The Synergy Micro-pump is a viable option for partial hemodynamic support in select heart failure patients.
  • It offers a less invasive approach compared to traditional LVADs.
  • This device can be crucial for bridging patients to transplantation with improved outcomes.

Keywords:
LVADcirculatepartial support devicesynergy

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.8K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.3K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
594
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
811
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
768